Articles by Anna Rose Welch

  1. EMA, CHMP, NICE News Roundup: AstraZeneca, Gilead, Novartis, And More 10/3/2014

    AstraZeneca received several articles of good news from European regulators recently. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion for Moventig (naloxegol) for patients with opioid-induced constipation (OIC) who have not been successfully treated with laxatives.